These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 745806

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blood rheology changes during bezafibrate treatment.
    Caimi G, Francavilla G, Romano A, Catania A, Santonocito G, Sarno A.
    Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
    Randi ML, Fabris F, Crociani ME, Battocchio F, Girolami A.
    Arzneimittelforschung; 1985 Nov; 35(12):1847-9. PubMed ID: 4096744
    [Abstract] [Full Text] [Related]

  • 5. Blood and plasma viscosity in experimentally induced hyper- and hypo-fibrinogenaemia.
    Pola P, Flore R, Tondi P.
    Int J Tissue React; 1986 Nov; 8(4):333-6. PubMed ID: 2943690
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Rheologic observations on blood viscosity in atherosclerosis (with dyslipidosis and peripheral obliterating arteriopathy)].
    Alberto S, Biasci R, Naldi R, Picco S, Dughera L.
    Minerva Cardioangiol; 1977 Nov; 25(7-8):629-35. PubMed ID: 927655
    [No Abstract] [Full Text] [Related]

  • 11. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G, Fellin R, Calabrò A, Baiocchi MR, Rossi A, Lenzi S, Descovich GC, Delmonte G, Gaddi A, Ventura A.
    Monogr Atheroscler; 1986 Nov; 14():215-21. PubMed ID: 3526129
    [No Abstract] [Full Text] [Related]

  • 12. [Plasma viscosity in atherosclerotic patients].
    Turczyński B, Sroczyński J, Kossmann S.
    Pol Tyg Lek; 1976 Aug 16; 31(33):1423-5. PubMed ID: 62351
    [No Abstract] [Full Text] [Related]

  • 13. [Hemorrheologic disorders in obese patients. Study of the viscosity of the blood, erythrocytes, plasma, fibrinogen and the erythrocyte filtration index].
    Craveri A, Tornaghi G, Paganardi L, Ranieri R, Leonardi G, Di Bella M.
    Minerva Med; 1987 Jul 15; 78(13):899-906. PubMed ID: 3601135
    [Abstract] [Full Text] [Related]

  • 14. Clopidogrel: hemorheological effects in subjects with subclinical atherosclerosis.
    Ciuffetti G, Lombardini R, Pirro M, Lupattelli G, Mannarino E.
    Clin Hemorheol Microcirc; 2001 Jul 15; 25(1):31-9. PubMed ID: 11790868
    [Abstract] [Full Text] [Related]

  • 15. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
    Jaeger BR, Bengel FM, Odaka K, Uberfuhr P, Labarrere CA, Bengsch S, Engelschalk C, Kreuzer E, Reichart B, Schwaiger M, Seidel D.
    J Heart Lung Transplant; 2005 Dec 15; 24(12):2022-30. PubMed ID: 16364844
    [Abstract] [Full Text] [Related]

  • 16. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C, Ritter MM, Richter WO, Minkenberg R, Schwandt P.
    Metabolism; 2001 Feb 15; 50(2):166-70. PubMed ID: 11229424
    [Abstract] [Full Text] [Related]

  • 17. [Hemorheological aspects in relation to age and to the presence of arteriosclerotic disease].
    Neirotti M, Molaschi M, Pernigotti L, Milla A, Fabris F.
    Ric Clin Lab; 1989 Feb 15; 19 Suppl 1():69-74. PubMed ID: 2629090
    [No Abstract] [Full Text] [Related]

  • 18. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
    Turczyński B, Sroczyński J, Antoszewski Z, Matyszczyk B, Krupa G, Grzegorczyn S.
    Pol Tyg Lek; 1989 Feb 15; 46(37-39):700-3. PubMed ID: 1669136
    [Abstract] [Full Text] [Related]

  • 19. Fibrinolytic effect of a particular glycosaminoglycan (endoglycan) per os on normals and in patients with chronic artery disease.
    Patrassi GM, Veronesi A, Sartori MT, Viero ML, Boeri G, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Feb 15; 117(3):369-76. PubMed ID: 1703105
    [Abstract] [Full Text] [Related]

  • 20. Rheological and clotting changes in the immediate post-myocardial infarction period.
    Patrassi GM, Brunetti A, de Zio A, Gribaldo A, Cafiero F, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Feb 15; 108(1):140-9. PubMed ID: 6164609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.